US 11,684,635 B2
Methods of treating chronic inflammatory diseases
Chong-Hwan Chang, Incheon (KR); and Keun-Yeong Jeong, Seoul (KR)
Assigned to METIMEDI PHARMACEUTICALS CO., LTD., Uiwang-si (KR)
Filed by METIMEDI PHARMACEUTICALS CO., LTD., Incheon (KR)
Filed on Dec. 23, 2020, as Appl. No. 17/131,820.
Application 17/131,820 is a continuation of application No. 16/942,757, filed on Jul. 29, 2020, granted, now 10,898,514.
Application 16/942,757 is a continuation of application No. 16/246,252, filed on Jan. 11, 2019, granted, now 10,751,365, issued on Aug. 25, 2020.
Claims priority of provisional application 62/616,923, filed on Jan. 12, 2018.
Prior Publication US 2021/0106614 A1, Apr. 15, 2021
Int. Cl. A61K 33/06 (2006.01); A61K 47/36 (2006.01); A61P 29/00 (2006.01); A61P 9/10 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61K 31/19 (2006.01); A61K 9/00 (2006.01); A61P 1/16 (2006.01)
CPC A61K 33/06 (2013.01) [A61K 9/00 (2013.01); A61K 31/19 (2013.01); A61K 47/36 (2013.01); A61P 1/16 (2018.01); A61P 9/10 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01)] 9 Claims
 
1. A method of treating inflammatory disease comprising:
administering to a subject in need thereof a pharmaceutical composition comprising:
a therapeutically effective amount of calcium lactate;
a polymer; and
a lipid,
wherein,
the weight ratio of the polymer to the lipid is 1:0.1 to 1:50; and
the inflammatory disease is pulpitis and or periodontitis.